| Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort BM Feldman, GE Rivard, P Babyn, JKM Wu, MG Steele, MC Poon, ... The Lancet Haematology 5 (6), e252-e260, 2018 | 52 | 2018 |
| A wearable activity tracker intervention for promoting physical activity in adolescents with juvenile idiopathic arthritis: a pilot study LD Heale, S Dover, YI Goh, VA Maksymiuk, GD Wells, BM Feldman Pediatric Rheumatology 16, 1-8, 2018 | 27 | 2018 |
| Improved disease course associated with early initiation of biologics in polyarticular juvenile idiopathic arthritis: trajectory analysis of a Childhood Arthritis and … MS Ong, S Ringold, Y Kimura, LE Schanberg, GA Tomlinson, MD Natter, ... Arthritis & Rheumatology 73 (10), 1910-1920, 2021 | 24 | 2021 |
| Musculoskeletal ultrasound in hemophilia: results and recommendations from a global survey and consensus meeting N Bakeer, S Dover, P Babyn, BM Feldman, A von Drygalski, AS Doria, ... Research and practice in thrombosis and haemostasis 5 (5), e12531, 2021 | 23 | 2021 |
| Use of ultrasound for assessment of musculoskeletal disease in persons with haemophilia: Results of an International Prophylaxis Study Group global survey DM Ignas, AS Doria, A von Drygalski, VS Blanchette, EY Chang, S Dover, ... Haemophilia 26 (4), 685-693, 2020 | 23 | 2020 |
| Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study S Dover, VS Blanchette, D Wrathall, E Pullenayegum, D Kazandjian, ... Research and Practice in Thrombosis and Haemostasis 4 (2), 318-325, 2020 | 21 | 2020 |
| Measuring the impact of changing from standard half‐life (SHL) to extended half‐life (EHL) FVIII prophylaxis on health‐related quality of life (HRQoL) in boys with moderate … M Carcao, L Zunino, NL Young, S Dover, V Bouskill, P Hilliard, VE Price, ... Haemophilia 26 (1), 73-78, 2020 | 20 | 2020 |
| Clinical outcomes in hemophilia: towards development of a core set of standardized outcome measures for research S Dover, VS Blanchette, A Srivastava, K Fischer, A Abad, BM Feldman, ... Research and practice in thrombosis and haemostasis 4 (4), 652-658, 2020 | 15 | 2020 |
| Juvenile spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: high biologic use, low prevalence of HLA–B27, and equal sex representation in … DG Rumsey, A Lougee, R Matsouaka, DH Collier, LE Schanberg, ... Arthritis Care & Research 73 (7), 940-946, 2021 | 14 | 2021 |
| Down Syndrome–Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes JT Jones, C Smith, ML Becker, D Lovell, CARRA Registry Investigators, ... Arthritis Care & Research 73 (12), 1739-1745, 2021 | 13 | 2021 |
| The effect of creatine supplementation on muscle function in childhood myositis: A randomized, double-blind, placebo-controlled feasibility study S Dover, S Stephens, JE Schneiderman, E Pullenayegum, GD Wells, ... The Journal of Rheumatology 48 (3), 434-441, 2021 | 12 | 2021 |
| Comparing the measurement properties and preferability of patient-reported outcome measures in pediatric rheumatology: PROMIS vs CHAQ J Craig, BM Feldman, L Spiegel, S Dover The Journal of Rheumatology 48 (7), 1065-1072, 2021 | 10 | 2021 |
| Disease recapture rates after medication discontinuation and flare in juvenile idiopathic arthritis: an observational study within the childhood arthritis and rheumatology … S Ringold, AC Dennos, Y Kimura, T Beukelman, P Shrader, TA Phillips, ... Arthritis Care & Research 75 (4), 715-723, 2023 | 7* | 2023 |
| Magnetic resonance imaging in boys with severe hemophilia A: Serial and end‐of‐study findings from the Canadian Hemophilia Primary Prophylaxis Study J Stimec, S Dover, E Pullenayegum, VS Blanchette, AS Doria, ... Research and Practice in Thrombosis and Haemostasis 5 (7), e12565, 2021 | 7 | 2021 |
| Updating the Canadian Hemophilia Outcomes–Kids’ Life Assessment Tool (CHO‐KLAT) in the era of extended half‐life clotting factor concentrates VE Price, S Dover, VS Blanchette, RJ Klaassen, M Belletrutti, AAK Bruce, ... Research and Practice in Thrombosis and Haemostasis 5 (3), 403-411, 2021 | 7 | 2021 |
| The clinical features of juvenile dermatomyositis: a single-centre inception cohort P Cancarini, T Nozawa, K Whitney, A Bell-Peter, JA Marcuz, A Taddio, ... Seminars in Arthritis and Rheumatism 57, 152104, 2022 | 6 | 2022 |
| Childhood‐Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short‐Term Kidney Status and Variation in Care EA Smitherman, RA Chahine, T Beukelman, LB Lewandowski, ... Arthritis Care & Research 75 (7), 1553-1562, 2023 | 5 | 2023 |
| Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis T Nozawa, A Bell-Peter, JA Marcuz, K Whitney, O Vinik, R Shupak, ... The Journal of Rheumatology 49 (11), 1250-1255, 2022 | 5 | 2022 |
| Correlation of a modified disease activity score (DAS) with the validated original DAS in patients with juvenile dermatomyositis H Clairman, S Dover, K Whitney, JA Marcuz, A Bell-Peter, BM Feldman The Journal of Rheumatology 48 (1), 101-104, 2021 | 4 | 2021 |
| Measuring Health Related Quality of Life (HRQoL) in boys with hemophilia using extended half-life clotting factor concentrates (CFCs) VE Price, S Dover, VS Blanchette, RJ Klaassen, C Wakefield, M Belletrutti Res Pract Thromb Haemost 3, 428, 2019 | 4 | 2019 |
